End-of-day quote Nasdaq 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
17.59 USD -.--% Intraday chart for CALYXTPAR +2.93% -10.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cibus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Cibus, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Cibus, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Cibus, Inc. Provides Impairment Charges Guidance for the Year Ended December 31, 2023 CI
Cibus, Inc. and Loveland Products Inc. Collaborate to Develop and Sell Rice Traits in the US CI
Cibus Nordic Real Estate Raises EUR50 Million from Senior Notes Issue MT
Cibus 2023 Field Trial Results Move Developed Traits Closer to Product Sales CI
Cibus, Inc. Announces Successfully Regenerated Plants from Single Cells in Wheat CI
Cibus Partners With Interoc on Herbicide Tolerance in Rica Hybrids for Latin America MT
Cibus Enters into A Latin America Collaboration Agreement with Interoc to Deliver Rice Growers an Innovative Rice Weed Control System CI
Sweden's Cibus Nordic Real Estate Names New CEO MT
Cibus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (CBUS) CIBUS US LLC Posts Q3 Revenue $475,000, vs. Street Est of $0.3M MT
Transcript : Cibus, Inc., Q3 2023 Earnings Call, Nov 09, 2023
Cibus Nordic Real Estate Divests EUR9 Million Properties in Finland MT
Cibus, Inc. announced that it expects to receive $80 million in funding CI
Cibus, Inc. Announces Resignation of Jim Collins as Member of Board of Directors and Member of Nominating and Corporate Governance Committee CI
Top Premarket Gainers MT
Iberian olive oil producers draw private-equity interest as prices soar RE
Cibus, Inc. Appoints Jim Collins to Board of Directors CI
Cibus Nordic Real Estate CEO to Depart MT
Transcript : Cibus, Inc., Q2 2023 Earnings Call, Aug 10, 2023
Cibus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Earnings Flash (CBUS) CIBUS US LLC Reports Q2 Revenue $197,000 MT
Cibus, Inc. Appoints Steve Berreth as General Counsel and Corporate Secretary for the Corporation CI
Chart CALYXTPAR
More charts
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
14.9 USD
Average target price
23 USD
Spread / Average Target
+54.36%
Consensus
  1. Stock Market
  2. Equities
  3. CLXT Stock
  4. News CALYXTPAR
  5. Calyxt : to Advance Plant-Based Synthetic Biology Solutions -- Shares Sharply Higher After-Hours